 This results in significant responses in patients and sustained disease control.By 2001 it was no longer doubted that this inhibitor can be effective and safe in humans.In similar manner, protein tyrosine kinase inhibitor STI571 was found to significantly reduce the physical size of tumors; they decreased roughly 65% in size in 4 months of trialing, and continued to diminish.